12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers ENDRA Life Sciences (NASDAQ:NDRA) stock increased by 71.6% to $0.15 during Wednesday’s pre-market session. The company’s market…
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Akanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday’s pre-market session. The company’s market cap…
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Akili (NASDAQ:AKLI) stock moved upwards by 70.1% to $0.4 during Tuesday’s regular session. The company’s market cap…
Infection-Focused Barinthus Bio’s VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives
Explore the latest findings from Barinthus Biotherapeutics on VTP-200's performance in the APOLLO trial for low-grade cervical lesions linked to persistent hrHPV infection. Positive trends were noted, though not statistically significant. No major safety concerns were observed.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday’s regular session. The market value…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers ARCA biopharma (NASDAQ:ABIO) shares moved upwards by 84.8% to $3.16 during Wednesday’s regular session. The market value…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 30.3% to $4.95 during Monday’s pre-market session. The market value of their…
Barinthus Bio Said Initial Data From The Combination Of Imdusiran And VTP-300 Show Meaningful Reductions Of HBsAg Levels That Were Maintained Well Below Baseline.
Initial data from the combination of imdusiran and VTP-300 show meaningful reductions of HBsAg levels that were maintained well below baseline.
In HBV003, 31% of participants with screening HBsAg level of ≤200